Theatres bet big on events

25%: Gen Z theatre-going increased 25% year-over-year and cinema loyalty club membership rose 15% since 2024, even as North American box office revenues slipped to about $9 billion in 2025 from roughly $10–11 billion pre-pandemic. Exhibitors are countering long-term decline by staging interactive, community-driven events (singalongs, themed drinking-game screenings, restorations, IMAX/VIP premium offerings) that boost attendance and convert newcomers into repeat customers. For portfolios, operators that effectively monetize experiential programming and loyalty should show more resilient foot traffic, but the sector remains structurally challenged by streaming and faster at-home windows.

Analysis

The profitable lever here is not ticket volume per se but revenue density per patron: curated event nights can push ancillary spend (F&B, merch, premium seating) by an incremental $3–$10 per head and raise frequency among high-LTV cohorts (young adults) by 10–25% on the specific weekday or slot converted to event programming. For publicly traded exposure, firms that supply differentiated premium distribution (large-format screens, unique licensing windows, and global re-release capabilities) capture a larger share of that incremental spend with lower incremental opex than local exhibitors that must retrofit auditoria and run higher-margin programming irregularly.

Near-term catalysts are studio negotiation outcomes on theatrical exclusivity (0–12 months) and calendar reissues tied to anniversaries/nostalgia (quarterly). Tail risks include a renewed acceleration of day-and-date releases or a consumer belt-tightening that pulls discretionary spend from events first; either could compress margins within 3–9 months. Over 12–24 months, winners will be those with asset-light capture of premium attendance (platforms that license IMAX-like windows) and loyalty programs that monetize repeat attendance without proportional staffing or CapEx increases.

Second-order winners include concession/merch suppliers, local experiential promoters, and ad-sales tied to live-event audiences; losers are mid-market chains that must invest capex to stay relevant and small independent cinemas that cannot scale programming. A pragmatic portfolio response is to favor businesses with asymmetric capture of experiential upside and contain exposure to regionals with heavy leverage and capex commitments.

Key Decisions for Investors

• Long IMAX (IMAX): buy shares or a 12-month 1:1 call spread (e.g., buy 12-month calls / sell higher strike) — target ~25% upside if global premium box office +10–15% over 12 months; hedge with 6–9 month puts sized to limit drawdown to 20%. Rationale: asset-light capture of premium event/reissue economics; downside if studios shorten windows.
• Pair trade — long IMAX / short CGX.TO (equal-dollar, 6–12 month horizon): expected positive spread if experiential premium consolidates at large-format providers while regional chains face margin pressure from retrofit and loyalty investments. Position risk: macro squeeze or outsized local rebound that benefits CGX.TO instead.
• Event-risk hedge on CGX.TO: if taking a directional long on CGX.TO, buy the equity with protective 9–12 month puts (strike ~20–30% OTM) or use a collar to cap downside. Objective: capture a 30–50% upside from loyalty/membership monetization scenarios while explicitly limiting bankruptcy/levered-capex tail risk.
• Tactical volatility trade on IMAX: sell short-dated implied vol (30–90 days) around non-tentpole calendar holes if implied vols spike pre-releases; use strict gamma risk limits. Rationale: recurring tailwinds from reissues make earnings lumpy but directional; avoid selling vol across major tentpoles.